OAMU
NVO

Ostrum Asset Management US’s Novo Nordisk NVO Stock Holding History

Ostrum Asset Management US’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$50K Hold
1,926
– – 0.01% 29
2018
Q4 		$44K Buy
+1,926
New +$42.8K 0.01% 241

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Ostrum Asset Management US's NVO Position: Q1 2019 in Review

Ostrum Asset Management US held its Novo Nordisk (NVO) position steady in Q1 2019 at 1,926 shares worth $50K. The position accounts for 0.01% of the portfolio, ranked #29.

Ostrum Asset Management US first reported a position in NVO in Q4 2018 and has held it in 2 quarters since. 580 funds tracked by Wall St. Rank hold NVO as of Q1 2019.

  • Ostrum Asset Management US held 1,926 shares of Novo Nordisk worth $50K as of Q1 2019.
  • Ostrum Asset Management US left its Novo Nordisk share count unchanged in Q1 2019.
  • Novo Nordisk made up 0.01% of Ostrum Asset Management US's portfolio in Q1 2019, its #29 holding.
  • Ostrum Asset Management US first reported a position in Novo Nordisk in Q4 2018 and has held it in 2 quarters since.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2019.

Based on Ostrum Asset Management US's 13F filing for Q1 2019, filed 15 May 2019.